Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

893 recalls · Class II, newest first

Class II · Moderate risk

Timolol-Latanoprost PF Solution

Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

Terminated Chemical / undeclared ImprimisRx CA, Inc., dba ImprimisRx D-1132-2017
Class II · Moderate risk

Latanoprost PF Solution

Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

Terminated Chemical / undeclared ImprimisRx CA, Inc., dba ImprimisRx D-1131-2017
Class II · Moderate risk

Cyclobenzaprine HCl Tablets

Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

Terminated Labeling / mix-up Apace KY LLC D-1036-2017
Class II · Moderate risk

Amantadine HCl Capsules

Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

Terminated Labeling / mix-up Apace KY LLC D-1035-2017
Class II · Moderate risk

Succinylcholine Chloride

Lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier

Terminated Sterility / contamination Fagron Compounding Services LLC dba Fagron Sterile Services D-0946-2017
Class II · Moderate risk

Ibuprofen Tablets

Presence of foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg.

Terminated Particulate / foreign matter Time-Cap Laboratories, Inc. NDC 49483-603-50 D-1055-2017

Recalls by year